Skip to content

Global Registry for Endovascular Aortic Treatment (GREAT)

'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01658787
Acronym
GREAT
Enrollment
4600
Registered
2012-08-07
Start date
2010-12-01
Completion date
2027-06-01
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Pathologies

Keywords

Aorta

Brief summary

Prospective, observational Registry to obtain data on device performance and clinical outcomes.

Detailed description

This is a prospective observational cohort Registry designed to obtain data on device performance and clinical outcomes of patients treated with Gore Endovascular Aortic products.

Interventions

Treatment with Gore Endovascular Aortic Products.

Sponsors

W.L.Gore & Associates
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Minimum age required by state regulations * Indication for aortic endovascular stent graft repair * Signed informed consent

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frame
To collect "real world" data on the incidence of serious device events.Up to 10 years

Countries

Australia, Brazil, Italy, United States

Contacts

PRINCIPAL_INVESTIGATORRoss Milner, MD, FACS

The University of Chicago Medicine & Biological Sciences

PRINCIPAL_INVESTIGATORDennis Gable, MD

Baylor Research Institute

PRINCIPAL_INVESTIGATORPierre Galvagni Silveira, MD, PhD

Coris Medicina Avançada

PRINCIPAL_INVESTIGATORSteven R Dubenec, MD

Royal Prince Alfred Hospital, Sydney, Australia

PRINCIPAL_INVESTIGATORSanti Trimarchi, MD

IRCCS Policlinico S. Donato

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026